期刊文献+

蛋白磷酸酶Ⅰ(PPP1R3)在直肠癌细胞体外侵袭转移的生物学活性研究 被引量:1

THE STUDY ON BIOLOGICAL ACTIVITY WITH INVASION AND METASTASIS OFVITRO RECTAL CANCER CELL BY PPP1R3
原文传递
导出
摘要 目的探讨研究蛋白磷酸酶I(protein phosphatase1 regulatory subunit 3,PPP1R3)在直肠癌SW480细胞中的黏附、运动、迁移和侵袭能力的生物学活性。方法用PPP1R3、EGFR抗体、VEGFR抗体干预SW480细胞后,分别对其行细胞运动实验、黏附实验、迁移及侵袭实验,分析PPP1R3对SW480细胞运动、黏附、迁移和侵袭能力的影响及其作用机制。结果随着PPP1R3浓度的增加,直肠癌SW480细胞的黏附、运动、迁移和侵袭能力明显减退(P<0.05)。而且穿过人工基底膜的能力明显减低(P<0.05)。结论 PPP1R3能够抑制直肠癌SW480体外的侵袭、转移作用,可为PPP1R3基因表达缺失的直肠癌术后患者提供放化疗、生物靶向治疗依据。 Objective To investigate whether the PPP1R3 enhances adherence,movement,invasion and metastasia capabilitier of rectal cancer cell(SW480). Methods Biological activities, such as adherence, movement,invasion and metastasia of SW480 cells ,were treatde by PPP1R3, EGFRantibody, VEGFRantibody, and the mechanism was investigated. Results The biological activities such as adherence, movement, invasion,metastasia and crossing the reconstituted basement membrane were failed with the increased con- centration of PPP1R3. Conclusion The abilities of vitro rectal cancer such as membrane,invasion are inhabited by PPP1R3. It can supply the evidence of chemotherapy and targeted biological therapy for the post- operative patients of Rectal cancer surgery with PPP1R3 gene deletion.
出处 《中国煤炭工业医学杂志》 2012年第4期475-478,共4页 Chinese Journal of Coal Industry Medicine
基金 江西省卫生厅资助课题(20090059)
关键词 直肠癌 蛋白磷酸酶Ⅰ 癌细胞体外侵袭转移 生物学活性 rectal cancer protein phosphatasel regulatory subunit 3 invasion and metastasia of cancer cells in vitro biological activity
  • 相关文献

参考文献14

  • 1Hagmann M. Science, 2000, 290:82
  • 2Bruchez M J, Moronne M, Gin P,et al. Science, 1998,281:2013
  • 3Vlatakis G, Andersson L, Muller R, et al. Nature, 1993,361: 645
  • 4Flam F. Science, 1994, 263:1221
  • 5Mosbach K, Remstrom O. Biotechnology, 1996, 14:163
  • 6Kriz D, Ramstrom O, Mosbach K. Anal Chem, 1997, 69:A345
  • 7Santra S, Wang K, Tapec R, et al. J Biomedical Optics,2001, 6 (2): 1
  • 8Haupt K, Mayes A G, Mosbach K. Anal Chem, 1998, 70:3936
  • 9Tyagi S, Kramer F R. Nature Biotechnol, 1996, 14:303
  • 10陈明卫,杨明功,徐希平,王长江,王佑民,刘树琴,章秋,孙海燕.PPP1R3基因多态性与中国汉族人群2型糖尿病的相关性研究[J].中国优生与遗传杂志,2003,11(6):25-27. 被引量:2

二级参考文献6

  • 1Mott DM, Kida Y, Nyomba BL. Human skeletal muscle, type-1 protein phosphatase and insulin resistance. Adv Prot Phosph,1993,7:413-427.
  • 2Hansen L, Hansen T, Vestergaard H, et al. Widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin. Hum Mol Genet, 1995,4:131
  • 3Xia J, Scherer SW, Cohen PT, et al. A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes.Diabetes , 1998,47:1519-1524.
  • 4Hansen L, Reneland R, Berglund L, et al. Polymorphism in the glycogen-associated regulatory subunit of type 1 protein phosphatase(PPP1R3) gene and insulin sensitivity. Diabetes, 2000,49:298-301.
  • 5Shen GQ, Ikegami H, Fujisawa T et al. Asp905Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM. Diabetes Care,1998,21 : 1086-1089.
  • 6钱荣立.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志,2000,8(1):5-6. 被引量:2311

共引文献2

同被引文献35

  • 1尤昭玲,刘慧萍,雷磊,赖毛华,何冬梅,邓菁英,王芳,周琼.正常妊娠与自然流产模型小鼠Th_1/Th_2型细胞因子表达的差异[J].中国中医药科技,2009,16(2):133-134. 被引量:16
  • 2袁水桥,罗光彬,张晓华,李东全,朱增娟.哺乳动物卵母细胞孤雌激活的研究进展[J].动物科学与动物医学,2004,21(12):1-3. 被引量:13
  • 3鄂玲玲,刘洪臣,王东胜.不同激活方法对小鼠卵母细胞孤雌激活胚胎发育的影响[J].解放军医学杂志,2007,32(1):16-19. 被引量:5
  • 4彭美莲,黄荷凤,金帆.卵母细胞人工孤雌激活研究进展[J].浙江大学学报(医学版),2007,36(3):307-312. 被引量:4
  • 5A Paffon, i TA L Brevin, i F Gandolfi, et al. Par- thenogenetic Activation: Biology and Applications in the ART Laboratory[J]. Placenta, 2008, 29: S121 - S125.
  • 6Karagenc L, Yalcin E, Ulug U, et al. Administra- tion of increasing amounts of gonadotrophin com- promises preimplantation development of parthe- nogenetic mouse embryos[J]. Reprod Biomed On- line,2004,8(6) :628- 634.
  • 7Chen DY. Fertilization biology[M]. Beijing: Sci- ence Publishing,2000:316.
  • 8Hipp J, Atala A. Tissue engineering, stem cells, cloning and parthenogenesis: new paradigms for therapy[J]. J Exp Clin Assist Reprod, 2004,1 (1) : 3.
  • 9Mizutani E, Jiang JY, Mizuno S, et al. Determina- tion of optimal conditions for parthenogenetic acti- vation and subsequent development of rat oocytes in vitro[J]. J Reprod Dev,2004,50(1) :139 - 146.
  • 10Taupin P. Parthenogenetically activated human oo- cytes and parthenogenetic embryonic stemcells[J]. Expert Opin Ther Pat ,2011,62(3) ..1281 - 1283.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部